TWIRLA (ethinyl estradiol; levonorgestrel) Agile Patent: 7,384,650 Expiration: Mar 14, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The pos…
Drug Patent Expirations for the Week of March 14, 2021 Read Post »
TWIRLA (ethinyl estradiol; levonorgestrel) Agile Patent: 7,384,650 Expiration: Mar 14, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The pos…
Drug Patent Expirations for the Week of March 14, 2021 Read Post »
Annual Drug Patent Expirations for BIKTARVY Biktarvy is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are eleven…
The post New patent expiration for Gilead Sciences drug BIKTARVY appeared fi…
New patent expiration for Gilead Sciences drug BIKTARVY Read Post »
Annual Drug Patent Expirations for SYMTUZA Symtuza is a drug marketed by Janssen Prods and is included in one NDA. It is available from one supplier. There are eleven patents…
The post New patent expiration for Janssen Prods drug SYMTUZA appeared first…
New patent expiration for Janssen Prods drug SYMTUZA Read Post »
Annual Drug Patent Expirations for ENJUVIA Enjuvia is a drug marketed by Aspen and is included in one NDA. There are two patents protecting this drug. This drug has seventeen…
The post New patent expiration for ASPEN drug ENJUVIA appeared first on Drug…
Annual Drug Patent Expirations for ORILISSA Orilissa is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent expiration for Abbvie Inc drug ORILISSA appeared first on …
New patent expiration for Abbvie Inc drug ORILISSA Read Post »
Annual Drug Patent Expirations for ORIAHNN+%28COPACKAGED%29 Oriahnn (copackaged) is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are five…
The post New patent expiration for Abbvie Inc drug ORIAHNN …
New patent expiration for Abbvie Inc drug ORIAHNN (COPACKAGED) Read Post »
Annual Drug Patent Expirations for NUPLAZID Nuplazid is a drug marketed by Acadia Pharms Inc and is included in two NDAs. It is available from one supplier. There are nineteen…
The post New patent expiration for Acadia Pharms drug NUPLAZID appeared fir…
New patent expiration for Acadia Pharms drug NUPLAZID Read Post »
Annual Drug Patent Expirations for PHEXXI Phexxi is a drug marketed by Evofem Inc and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent expiration for Evofem Inc drug PHEXXI appeared first on DrugPate…
New patent expiration for Evofem Inc drug PHEXXI Read Post »
ANDROGEL (testosterone) Abbvie Patent: 6,503,894 Expiration: Mar 2, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pat…
Drug Patent Expirations for the Week of February 28, 2021 Read Post »